1. Home
  2. STBX vs LEXX Comparison

STBX vs LEXX Comparison

Compare STBX & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STBX
  • LEXX
  • Stock Information
  • Founded
  • STBX 2019
  • LEXX 2004
  • Country
  • STBX Malaysia
  • LEXX Canada
  • Employees
  • STBX N/A
  • LEXX 7
  • Industry
  • STBX Advertising
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • STBX Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • STBX Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • STBX 51.1M
  • LEXX 38.9M
  • IPO Year
  • STBX 2022
  • LEXX N/A
  • Fundamental
  • Price
  • STBX $1.95
  • LEXX $2.23
  • Analyst Decision
  • STBX
  • LEXX Strong Buy
  • Analyst Count
  • STBX 0
  • LEXX 2
  • Target Price
  • STBX N/A
  • LEXX $11.00
  • AVG Volume (30 Days)
  • STBX 79.9K
  • LEXX 202.4K
  • Earning Date
  • STBX 12-27-2024
  • LEXX 01-10-2025
  • Dividend Yield
  • STBX N/A
  • LEXX N/A
  • EPS Growth
  • STBX N/A
  • LEXX N/A
  • EPS
  • STBX N/A
  • LEXX N/A
  • Revenue
  • STBX $12,213,183.00
  • LEXX $464,278.00
  • Revenue This Year
  • STBX N/A
  • LEXX $20.39
  • Revenue Next Year
  • STBX N/A
  • LEXX $113.25
  • P/E Ratio
  • STBX N/A
  • LEXX N/A
  • Revenue Growth
  • STBX 48.08
  • LEXX 105.24
  • 52 Week Low
  • STBX $1.05
  • LEXX $1.20
  • 52 Week High
  • STBX $6.32
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • STBX 65.98
  • LEXX 47.23
  • Support Level
  • STBX $1.29
  • LEXX $2.00
  • Resistance Level
  • STBX $2.04
  • LEXX $2.54
  • Average True Range (ATR)
  • STBX 0.29
  • LEXX 0.24
  • MACD
  • STBX 0.09
  • LEXX -0.00
  • Stochastic Oscillator
  • STBX 83.72
  • LEXX 27.06

About STBX Starbox Group Holdings Ltd.

Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: